相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Treatment of systemic lupus erythematosus: new advances in targeted therapy
Mindy S. Lo et al.
YEAR IN IMMUNOLOGY (2012)
Btk levels set the threshold for B-cell activation and negative selection of autoreactive B cells in mice
Laurens P. Kil et al.
BLOOD (2012)
The kinase Btk negatively regulates the production of reactive oxygen species and stimulation-induced apoptosis in human neutrophils
Fumiko Honda et al.
NATURE IMMUNOLOGY (2012)
Neutrophil development and function critically depend on Bruton tyrosine kinase in a mouse model of X-linked agammaglobulinemia
Katja Fiedler et al.
BLOOD (2011)
Bruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765
Sarah E. M. Herman et al.
BLOOD (2011)
Targeting lymphocyte signaling pathways as a therapeutic approach to systemic lupus erythematosus
Vasileios C. Kyttaris et al.
CURRENT OPINION IN RHEUMATOLOGY (2011)
Bruton's Tyrosine Kinase Is Required for TLR-Dependent Heme Oxygenase-1 Gene Activation via Nrf2 in Macrophages
Vijith Vijayan et al.
JOURNAL OF IMMUNOLOGY (2011)
The Bruton tyrosine kinase inhibitor PCI-32765 ameliorates autoimmune arthritis by inhibition of multiple effector cells
Betty Y. Chang et al.
ARTHRITIS RESEARCH & THERAPY (2011)
Efficacy and Safety of Rituximab in Moderately-to-Severely Active Systemic Lupus Erythematosus The Randomized, Double-Blind, Phase II/III Systemic Lupus Erythematosus Evaluation of Rituximab Trial
Joan T. Merrill et al.
ARTHRITIS AND RHEUMATISM (2010)
Tyrosine kinase Btk regulates E-selectin-mediated integrin activation and neutrophil recruitment by controlling phospholipase C (PLC) γ2 and PI3Kγ pathways
Helena Mueller et al.
BLOOD (2010)
Separate checkpoints regulate splenic plasma cell accumulation and IgG autoantibody production in Lyn-deficient mice
Toni Gutierrez et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
Constitutive activation of Bruton's tyrosine kinase induces the formation of autoreactive IgM plasma cells
Rogier Kersseboom et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
B Cell Subsets Contribute to Renal Injury and Renal Protection after Ischemia/Reperfusion
Brandon Renner et al.
JOURNAL OF IMMUNOLOGY (2010)
The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy
Lee A. Honigberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Bruton's tyrosine kinase (Btk): function, regulation, and transformation with special emphasis on the PH domain
Abdalla J. Mohamed et al.
IMMUNOLOGICAL REVIEWS (2009)
The Lupus Susceptibility Locus Sle1 Breaches Peripheral B Cell Tolerance at the Antibody-Forming Cell and Germinal Center Checkpoints
Raja Vuyyuru et al.
JOURNAL OF IMMUNOLOGY (2009)
B cells and tertiary lymphoid organs in renal inflammation
S. Segerer et al.
KIDNEY INTERNATIONAL (2008)
Btk regulates localization, in vivo activation, and class switching of anti-DNA B cells
Kristina E. Halcomb et al.
MOLECULAR IMMUNOLOGY (2008)
Shared signaling networks active in B cells isolated from genetically distinct mouse models of lupus
Tianfu Wu et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Bruton's tyrosine kinase prevents activation of the anti-apoptotic transcription factor STAT3 and promotes apoptosis in neoplastic B-cells and B-cell precursors exposed to oxidative stress
Fatih Uckun et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
The contribution of B cells to renal interstitial inflammation
Florian Heller et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Canonical NF-κB activity, dispensable for B cell development, replaces BAFF-receptor signals and promotes B cell proliferation upon activation
Yoshiteru Sasaki et al.
IMMUNITY (2006)
Regulation of dendritic cell maturation and function by Bruton's tyrosine kinase via IL-10 and Stat3
Y Kawakami et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Btk plays a crucial role in the amplification of FcεRI-mediated mast cell activation by Kit
S Iwaki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
T cell hyperactivity in lupus as a consequence of hyperstimulatory antigen-presenting cells
JK Zhu et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Pleiotropic consequences of Bruton tyrosine kinase deficiency in myeloid lineages lead to poor inflammatory responses
A Mangla et al.
BLOOD (2004)
Bruton's tyrosine kinase is a toll/interleukin-1 receptor domain-binding protein that participates in nuclear factor κB activation by toll-like receptor 4
CA Jefferies et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Genetic reconstitution of systemic lupus erythematosus immunopathology with polycongenic murine strains
L Morel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
A sensitized genetic system for the analysis of murine B lymphocyte signal transduction pathways dependent on Bruton's tyrosine kinase
AB Satterthwaite et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Bruton's tyrosine kinase is required for activation of IκB kinase and nuclear factor κB in response to B cell receptor engagement
JB Petro et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Bruton's tyrosine kinase links the B cell receptor to nuclear factor κB activation
UD Bajpai et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
分享论文
